Virus Titration - an overview | ScienceDirect Topics
Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge- dose study | PLOS ONE
The Tissue Culture Infectious Dose50 (TCID50) and the Plaque Assay - Fraunhofer IGB
Figure 2 from Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. | Semantic Scholar
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells - ScienceDirect
BioTek Applications: Virology TCID50
Recce Pharmaceuticals Announces Preclinical SARS-CoV-2 Study Update | BioSpace
Plaque Assay - an overview | ScienceDirect Topics
Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. | Semantic Scholar
Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models: Molecular Therapy - Methods & Clinical Development
Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity - ScienceDirect
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells - ScienceDirect
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays | Nature Protocols
Median Tissue Culture Infective Dose (TCID 50 ) of Influenza Virus... | Download Table
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells - ScienceDirect
Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples | Scientific Reports